18 June 2020 Image:ThisIsEngineering BIA Separations has introduced its novel PrimaS ligand technology. The proprietary multi-use platform faciliates high-resolution and high speed processing and says BIA, addresses many critical separation problems in fast emerging advanced therapy medicinal products (ATMPs). BIA Separations has introduced its novel PrimaS ligand technology. Read More
Avacta Group, in collaboration with the Centre for Virus Research at the University of Glasgow, has shown that Affimer reagents which bind to the SARS-COV-2 virus spike protein, prevent infection of human cells by a SARS-COV-2 model virus and therefore provide a potential therapy for COVID-19 infection. Avacta… Read More
Cobra Biologics will provide GMP manufacture of the adenovirus vector-based COVID-19 vaccine candidate AZD1222, previously known as ChAdOx1 n-CoV-19. Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, has signed a supply agreement with AstraZeneca UK to provide GMP manufacture of the adenovirus vector-based… Read More
Novasep, viral vector producer, has signed a partnership with AstraZeneca for the production of the Oxford University COVID-19 vaccine. Novasep will produce the active substance of the vaccine in its Belgian facilities The partnership follows the agreement between AstraZeneca and the Inclusive Alliance for Vaccines (IAV), to supply… Read More
17 June 2020 Ubiquigent is continuing its collaboration with Bristol Myers Squibb. The collaboration, originally between Ubiquigent and Celgene, will allow Bristol Myers Squibb to capitalise on Ubiquigent’s deubiquitylase (DUB) enzyme inhibitor drug discovery platform. The central role of ubiquitylation in diverse cellular processes, including protein degradation, makes… Read More
17 June 2020 This is the second tranche of growth capital loan signed with the European Investment Bank in May 2019. The new funds will be used for the development, manufacture and commercialisation of in vitro diagnostics for infectious diseases Mobidiag, a revenue generating, molecular diagnostics company with… Read More
16 June, 2020 The global science-led biopharmaceutical company said the detailed results from both the Phase II ACE-CL-001 trial and the pivotal Phase III ASCEND trial showed the long-term efficacy and tolerability of Calquence (acalabrutinib) in chronic lymphocytic leukaemia (CLL), one of the most common types of adult… Read More
15 June, 2020 Kite, which is part of research-based biopharmaceutical company Gilead Sciences, announced it has received approval to implement a variation to the Yescarta (axicabtagene ciloleucel) Marketing Authorisation from the European Medicines Agency (EMA) for end-to-end manufacturing at its facility located in Amsterdam, The Netherlands. With this… Read More
12 June, 2020 UK based PCR Biosystems, has launched qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2. PCR Biosystems said the new kit, which marks the latest addition to its specialised RT-qPCR offering, enables… Read More
11 June, 2020 The British-Swedish multinational is to present new data from the landmark Phase III DAPA-HF and DECLARE-TIMI 58 trials at the upcoming 80th American Diabetes Association (ADA) Virtual Scientific Sessions, taking place June 12-26. According to AstraZeneca, the data to be presented is among 23 accepted… Read More
10 June, 2020 The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, has launched a new series of programmes to help organisations collaborate on advancing the role of digital technology within life sciences R&D and healthcare. As part of… Read More
09 June, 2020 The specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications announced the successful closure of a £1.5 million (US$1.9 million) series A investment round to accelerate the global scale-up of its commercial operations. According to Cambridge based Qkine, the funding… Read More
8 June, 2020 The UK based gene and cell therapy group announced that it has signed a collaboration agreement on June 8 with the Vaccines Manufacturing and Innovation Centre (VMIC) to provide the UK’s first strategic vaccine development and advanced manufacturing capability. According to Oxford Biomedica, the five-year… Read More
05 June, 2020 Janssen Pharmaceuticals has announced that new data from two phase 3 trials Discover-1 and Discover-2 showed that TREMFYA (guselkumab) maintained improvements in multiple clinical outcomes in adult patients with active psoriatic arthritis (PsA). The Janssen Pharmaceutical Companies of Johnson & Johnson said that new data… Read More
The Finnish molecular diagnostics company announced it has received CE-IVD markings for its Novodiag Covid-19 and Amplidiag Covid-19 molecular diagnostic tests for the early detection of the SARS-CoV-2 virus. These tests complement Mobidiag’s already available antibody test, Anti-SARS-CoV-2 Rapid Test, that the company is distributing from its joint… Read More
02 June, 2020 The developer and manufacturer of innovative laboratory tools for process optimisation, safety and scale-up, has announced the appointment of a new General Manager and Senior Vice President of North American Operations. Mert Sahin has been appointed as General Manager and Senior Vice President of H.E.L… Read More
